Kaku K, Kadowaki T, Seino Y, Okamoto T, et al. Efficacy and Safety of Ipragliflozin in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control on Sitagliptin. Diabetes Obes Metab 2021 May 25. doi: 10.1111/dom.14448.
PMID: 34033212